Humatrix
tradename; myoepithelial matrical gel containing EGF, IGF-1, basement membrane and non-basement membrane molecules, including large amounts of chondroitin sulfate proteoglycan
Also Known As:
Humatrix Microclysmic Gel
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Neoplasm Metastasis (Metastasis)
|
2. | Wounds and Injuries (Trauma)
|
3. | Neoplasms (Cancer)
11/01/1997
- " HMS-X, HMS-3X, HMS-4X, and Humatrix inhibit tumor invasion and metastasis in severe combined immunodeficient mice (P < 0.001). " 11/01/1997
- " Humatrix, a gel that we have derived from HMS-X, inhibits tumor cell invasion (down to 25% +/- 10% of Matrigel control; P < 0.01), and our recently established human myoepithelial cell lines, HMS-1, HMS-3, and HMS-4, inhibit tumor cell invasion in cellular invasion (down to 42% +/- 7% of control; P < 0.05) and in conditioned media assays (down to 30% +/- 8% of control; P < 0.01). "
|
4. | Carcinoma (Carcinomatosis)
|
|
Related Drugs and Biologics